Login to Your Account



Ophthotech Raises $175M for Solo Run in Phase III

By Catherine Shaffer
Staff Writer

Tuesday, May 28, 2013

At a time when a majority of biotech companies are partnering up with big pharma for Phase III trials, Ophthotech Corp., of Princeton, N.J., is building a war chest to go it alone.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription